Report of Foreign Issuer (6-k)
April 23 2018 - 7:05AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.
20549
Form
6-K
REPORT
OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES
EXCHANGE ACT OF 1934
For
the Month of April 2018
Commission
File Number: 001-38104
IMMURON
LIMITED
(Name of Registrant)
Level 3, 62 Lygon Street,
Carlton South, Victoria, 3053, Australia
(Address of principal executive office)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Indicate
by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information
to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes
☐ No ☒
If
Yes is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):
82-
IMMURON
LIMITED
EXPLANATORY
NOTE
Immuron
Limited (the Company) published an announcement (the Public Notice) to the Australian Securities
Exchange on April 23, 2018 titled Travelan Sales Continue to Soar in Third Quarter of FY2018.
A
copy of the Public Notice is attached as an exhibit to this report on Form 6-K.
This
report on Form 6-K (including the exhibit hereto) shall not be deemed to be filed for purposes of the Securities
Exchange Act of 1934, as amended (the Exchange Act) and shall not be incorporated by reference into any filing
under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
EXHIBITS
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
IMMURON
LIMITED
|
|
|
|
|
|
|
Date:
April 23, 2018
|
By:
|
/s/
Peter Vaughan
|
|
|
Peter
Vaughan
|
|
|
Joint
Chief Financial Officer
|
Immuron (NASDAQ:IMRN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Immuron (NASDAQ:IMRN)
Historical Stock Chart
From Apr 2023 to Apr 2024